-+ 0.00%
-+ 0.00%
-+ 0.00%

Rocket Pharmaceuticals Q1 EPS $(0.42) Beats $(0.43) Estimate

Benzinga·05/07/2026 20:24:02
Listen to the news
Rocket Pharmaceuticals (NASDAQ:RCKT) reported quarterly losses of $(0.42) per share which beat the analyst consensus estimate of $(0.43) by 2.33 percent. This is a 25 percent increase over losses of $(0.56) per share from the same period last year.